Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.
about
Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsLong-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study.Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine developmentThymosin alpha 1 and HIV-1: recent advances and future perspectives.Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.
P2860
Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Qualitative immune modulation ...... sponder HIV-infected patients.
@ast
Qualitative immune modulation ...... sponder HIV-infected patients.
@en
type
label
Qualitative immune modulation ...... sponder HIV-infected patients.
@ast
Qualitative immune modulation ...... sponder HIV-infected patients.
@en
prefLabel
Qualitative immune modulation ...... sponder HIV-infected patients.
@ast
Qualitative immune modulation ...... sponder HIV-infected patients.
@en
P2093
P2860
P50
P1433
P1476
Qualitative immune modulation ...... sponder HIV-infected patients.
@en
P2093
Fabio Franzetti
Francesca Sabbatini
Giulio Ferrario
P2860
P304
P356
10.1371/JOURNAL.PONE.0014119
P407
P577
2010-11-29T00:00:00Z